Advanced Enzyme Technologies

Advanced Enzyme Technologies FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Advanced Enzyme Technologies (ADVENZYMES.NS) as of Oct 17, 2026 is 71.32 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 87.93 % — a change of -18.89% (lower).

FCF Conversion

71.32 %

YoY

-18.89%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Advanced Enzyme Technologies is 2026 71.32 % . FCF Conversion Rate (FCF/EBITDA) of Advanced Enzyme Technologies was 2025 87.93 % . It decreases by -18.89% lower compared to the previous year.

The Advanced Enzyme Technologies FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2019
104.61 INR
Jan 1, 2020
69.80 INR
Jan 1, 2021
98.21 INR
Jan 1, 2022
78.70 INR
Jan 1, 2023
96.73 INR
Jan 1, 2024
74.31 INR
Jan 1, 2025
87.93 INR
Jan 1, 2026
71.32 INR
The Advanced Enzyme Technologies FCF Conversion history
YEARFCF ConversionYoY
71.32 %-18.89%
87.93 %+18.33%
74.31 %-23.18%
96.73 %+22.90%
78.70 %-19.86%
98.21 %+40.69%
69.80 %-33.28%
104.61 %-10.30%
116.62 %+10.67%
105.38 %-9.10%
115.93 %+43.71%
80.67 %-65.37%
232.93 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Advanced Enzyme Technologies Stock analysis

What does Advanced Enzyme Technologies do? Advanced Enzyme Technologies Ltd is a company based in Thane, India, operating within the Materials sector, specifically in the Chemicals industry. The company focuses on the research, development, manufacture, and sale of enzyme products, employing 338 full-time staff. It completed its initial public offering (IPO) on August 1, 2016. Advanced Enzyme Technologies develops and markets a range of enzyme-based products derived from indigenous sources, including over 68 types of enzymes and probiotics. The company serves various industries, such as human health care and nutrition, animal nutrition, baking, fruit and vegetable processing, brewing, malting, grain processing, protein modification, dairy processing, textile processing, and others. Its product portfolio includes solutions for human nutrition featuring serratiopeptidase, fungal lactase, fungal lipase, and papain; animal nutrition products like DigeGrain X, DigeGrain XL, and DigeGrain M; food processing solutions for dairy and cheese, as well as yeast processing; and non-food applications in textile processing, leather, and biofuels. The company also provides services related to oils and fats processing, including oil extraction and refining. Advanced Enzyme Technologies Ltd maintains a website at https://www.advancedenzymes.com/ for further information about its operations and offerings. Advanced Enzyme Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Advanced Enzyme Technologies stock

FCF Conversion Rate (FCF/EBITDA) of Advanced Enzyme Technologies is 71.32 % in 2026.

FCF Conversion Rate (FCF/EBITDA) of Advanced Enzyme Technologies changed from 87.93 % to 71.32 %, representing a -18.89% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Advanced Enzyme Technologies since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Advanced Enzyme Technologies with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Advanced Enzyme Technologies

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Advanced Enzyme Technologies